---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Drugs Approved for Pheochromocytoma and Paraganglioma - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/pheochromocytoma-paraganglioma
version: v1
---

# Drugs Approved for Pheochromocytoma and Paraganglioma - NCI

# Drugs Approved for Pheochromocytoma and Paraganglioma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for pheochromocytoma and paraganglioma. The list includes generic names and brand names. The drug names link to NCIâ€™s Cancer Drug Information summaries. There may be drugs used in pheochromocytoma and paraganglioma that are not listed here.

## Drugs Approved for Pheochromocytoma

[Azedra (Iobenguane I 131)](/about-cancer/treatment/drugs/iobenguanei131)
[Hemangeol (Propranolol Hydrochloride)](/about-cancer/treatment/drugs/propranolol-hydrochloride)
[Iobenguane I 131](/about-cancer/treatment/drugs/iobenguanei131)
[Propranolol Hydrochloride](/about-cancer/treatment/drugs/propranolol-hydrochloride)

## Drugs Approved for Paraganglioma

[Azedra (Iobenguane I 131)](/about-cancer/treatment/drugs/iobenguanei131)
[Iobenguane I 131](/about-cancer/treatment/drugs/iobenguanei131)
